Seriniquinones, melanoma-specific anticancer agents

US9481662B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• William Fenical · Del Mar, US
• Paul Jensen · San Diego, US
• James J. La Clair · San Diego, US
• Lynnie Trzoss · San Diego, US
• Takashi Fukuda · Ibaraki, JP

Key dates

• Filing date: Jan 27, 2015
• Grant date: Nov 1, 2016
• Expiry date: Jan 27, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/381
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There are provided, inter alia, derivatives of seriniquinone and methods useful for the treatment of cancer, and in particular treatment of melanoma and prostate cancer.